Yoshinobu Koyama, MD, PhD

Japanese Red Cross Okayama Hospital
Okayama, Japan

Director, Center for Autoimmune Diseases,
Division of Rheumatology

Presentation(s):

• 1167: Transcriptome Analysis of Peripheral Blood Reveals Superiority of the Triple Combination of Baricitinib, Rituximab, and Tacrolimus Therapy (BRT-Tx.) for anti-MDA5 Antibody-positive Dermatomyositis (MDA5-DM)

  Monday, November 13, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.

• 2171: Common IL-6 Signaling Is Inhibited by IL-6 Inhibitors and JAK Inhibitors, but Which Is Better at Preventing Bone Destruction in RA?

  Tuesday, November 14, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.